Name: Name:Benzamide, N-[3-[[5-chloro-4-(1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-4-[[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]amino]-
Brand: AABLOCKS
SKU: AA001RUZ
Rating: 90 (10 reviews)

Catalog No.: AA001RUZ

1604810-83-4 | Benzamide, N-[3-[[5-chloro-4-(1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-4-[[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]amino]-

Pack Size： 1mg

Purity： 98% by HPLC

in stock

$88.00 $61.00

Pack Size： 5mg

Purity： ≥95%

in stock

$198.00 $138.00

Pack Size： 10mg

Purity： 95%

in stock

$314.00 $220.00

Pack Size： 25mg

Purity： 95%

in stock

$589.00 $412.00

Pack Size： 50mg

Purity： 96%

in stock

$932.00 $653.00

Pack Size： 100mg

Purity： 95%

in stock

$1,239.00 $868.00

Quantity

- +

Add to Card

Order Now

bulk Quotation Request

Technical Information

Catalog Number: AA001RUZ

Chemical Name: Benzamide, N-[3-[[5-chloro-4-(1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-4-[[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]amino]-

CAS Number: 1604810-83-4

Molecular Formula: C31H28ClN7O2

Molecular Weight: 566.0527

MDL Number: MFCD28167785

SMILES: CN(C/C=C/C(=O)Nc1ccc(cc1)C(=O)Nc1cccc(c1)Nc1ncc(c(n1)c1c[nH]c2c1cccc2)Cl)C

Properties

Complexity: 896

Covalently-Bonded Unit Count: 1

Defined Atom Stereocenter Count: 0

Defined Bond Stereocenter Count: 1

Formal Charge: 0

Heavy Atom Count: 41

Hydrogen Bond Acceptor Count: 6

Hydrogen Bond Donor Count: 4

Isotope Atom Count: 0

Rotatable Bond Count: 9

Undefined Atom Stereocenter Count: 0

Undefined Bond Stereocenter Count: 0

XLogP3: 4.8

Literature fold

Title: Targeting transcription regulation in cancer with a covalent CDK7 inhibitor.

Journal: Nature20140731

Title: Kwiatkowski N, et al. Targeting transcription regulation in cancer with a covalent CDK7 inhibitor. Nature. 2014 Jul 31;511(7511):616-20.

Title: Zeng M, et al. Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13. Elife. 2018 Nov 13;7. pii: e39030.

Title: Christensen CL, et al. Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor. Cancer Cell. 2014 Dec 8;26(6):909-22.

Title: Chipumuro, et al. CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer. Cell. 2014 Nov 20;159(5):1126-39. ?

Title: Jiang YY, et al. Targeting super-enhancer-associated oncogenes in oesophageal squamous cell carcinoma. Gut. 2016 May 10. pii: gutjnl-2016-311818.